We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$230B
AUM Growth
+$18.4B
Cap. Flow
-$8.18B
Cap. Flow %
-3.55%
Top 10 Hldgs %
23.04%
Holding
10,299
New
1,220
Increased
3,476
Reduced
4,117
Closed
1,266

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$615M
2
UBER icon
Uber
UBER
+$551M
3
EXPE icon
Expedia Group
EXPE
+$523M
4
PYPL icon
PayPal
PYPL
+$452M
5
ETN icon
Eaton
ETN
+$408M

Sector Composition

Rank Sector Weight
1 Technology 5.29%
2 Financials 4.55%
3 Industrials 4.18%
4 Healthcare 4.08%
5 Consumer Discretionary 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRS
8526
CALL
DELISTED
Antares Pharma, Inc.
ATRS
$60K ﹤0.01%
+12,700
New +$52K
MVIS icon
8527
CALL
Microvision
MVIS
$52.6M
$59K ﹤0.01%
5,427
+1,780
+49% +$19.6K
SNDL icon
8528
CALL
Sundial Growers
SNDL
$313M
$59K ﹤0.01%
1,960
+110
+6% +$3.59K
AVGR
8529
DELISTED
Avinger, Inc. Common Stock
AVGR
$59K ﹤0.01%
173
+38
+28% +$13.3K
USX
8530
PUT
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$59K ﹤0.01%
+11,700
New +$57K
RFP
8531
PUT
DELISTED
Resolute Forest Products Inc.
RFP
$59K ﹤0.01%
+14,100
New +$58.6K
TEUM
8532
CALL
DELISTED
Pareteum Corporation
TEUM
$59K ﹤0.01%
134,500
-89,400
-40% -$51.6K
OCUL icon
8533
PUT
Ocular Therapeutix
OCUL
$2.16B
$58K ﹤0.01%
14,800
-8,300
-36% -$28.9K
TLPH icon
8534
Talphera
TLPH
$62.3M
$58K ﹤0.01%
1,385
-1,550
-53% -$63.3K
GRCE
8535
Grace Therapeutics
GRCE
$44.8M
$58K ﹤0.01%
494
-42
-8% -$4.15K
DTEA
8536
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$58K ﹤0.01%
39,788
+14,773
+59% +$24.7K
CLNE icon
8537
PUT
Clean Energy Fuels
CLNE
$401M
$57K ﹤0.01%
24,300
+12,400
+104% +$26.3K
FURY
8538
Fury Gold Mines
FURY
$118M
$57K ﹤0.01%
17,906
+719
+4% +$2.12K
NL icon
8539
NLI Holdings
NL
$317M
$57K ﹤0.01%
14,455
+4,045
+39% +$16.6K
ATYR
8540
aTyr Pharma
ATYR
$56.9M
$57K ﹤0.01%
+13,774
New +$53.2K
CASA
8541
CALL
DELISTED
Casa Systems, Inc. Common Stock
CASA
$57K ﹤0.01%
+13,900
New +$66.4K
LSAK icon
8542
Lesaka Technologies
LSAK
$407M
$56K ﹤0.01%
+15,172
New +$50.3K
AMRS
8543
DELISTED
Amyris Inc.
AMRS
$56K ﹤0.01%
17,987
-8,880
-33% -$32.9K
SIOX
8544
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$56K ﹤0.01%
+10,900
New +$60.5K
LAC
8545
DELISTED
Lithium Americas Corp. Common Shares
LAC
$56K ﹤0.01%
17,536
-3,577
-17% -$10.9K
CARM
8546
CALL
DELISTED
Carisma Therapeutics
CARM
$55K ﹤0.01%
2,625
+905
+53% +$20.8K
GALT icon
8547
PUT
Galectin Therapeutics
GALT
$357M
$55K ﹤0.01%
19,200
-16,800
-47% -$58.4K
MDWD icon
8548
MediWound
MDWD
$174M
$55K ﹤0.01%
+2,560
New +$53.1K
MMLP icon
8549
CALL
Martin Midstream Partners
MMLP
$95.1M
$55K ﹤0.01%
+13,700
New +$60K
CTRC
8550
DELISTED
Centric Brands Inc. Common Stock
CTRC
$55K ﹤0.01%
+25,214
New +$63K

Similar funds

Ken Griffin's Q4 2019 Portfolio in Review

As of Q4 2019, Ken Griffin held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ken Griffin opened a new position in Interxion Holding N.V. worth $83.9M.

  • Ken Griffin's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
  • Ken Griffin added most to Amazon in Q4 2019, an estimated $615M increase.
  • Ken Griffin's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
  • Ken Griffin fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
  • Ken Griffin's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
  • Ken Griffin opened 1,220 new positions and closed 1,266 in Q4 2019.
  • Ken Griffin's portfolio value rose 8.7% quarter-over-quarter to $230B.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.